Nurlan Brimkulov

Nurlan Brimkulov

Auto-generated profile, based on publicly available information

Nurlan Brimkulov

I.K. Akhunbaev Kyrgyz State Medical Academy

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Journal of Smoking Cessation
Verified
Journal Article
Closed access
PDF file
DVDenis Vinnikov
Denis Vinnikov
NBNurlan Brimkulov
Nurlan Brimkulov
ABAichurek Burjubaeva
Aichurek Burjubaeva
Among many studies on cytisine only a few have been controlled trials, and the aim of this study was to assess the efficacy of cytisine in a randomized controlled double-blind trial compared to placebo in medium-dependent smoking men working in mining industry. Materials and methods: 171 middle-aged smokers were randomised to either cytisine (25-days regimen) or placebo; both groups received individual counseling with brochure. Self-reported continuous abstinence was assessed at 8 and 26 weeks. Results: At the end of week 8 there were no differences in number of abstinent subjects, but at 26 weeks 10.6% of subjects were abstinent in cytisine group compared to 1.2% in placebo (p = .01). In both groups, we did not find any weight increase, but quality of life improved in both groups, and physical and social functioning improved in cytisine group. Conclusions: Cytisine may be an effective medication to help smokers quit even for those working in difficult working conditions with high relapse rate.

1 April 2016 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
DVDenis Vinnikov
Denis Vinnikov
AKAbdullah Khafagy
Abdullah Khafagy
PBPaul D. Blanc
Paul D. Blanc
NBNurlan Brimkulov
Nurlan Brimkulov
CSCraig Steinmaus
Craig Steinmaus
We used meta-analysis to measure the effect of high-altitude climate therapy (HACT) on lung function outcomes in asthma, and systematically searched PubMed, Embase andwww.elibrary.rufor publications appearing from 1970 to mid-2015. We included studies carried out with children or adults with an exposure of up to 12 weeks at an altitude of ≥1500 m above sea level. Changes in forced expiratory volume in 1 s (FEV1), FEV1/vital capacity ratio or peak expiratory flow rate as the HACT intervention outcomes were analysed. We included data for 907 participants (age range 4–58 years) from 21 studies, altogether including 28 substrata based on asthma type or severity. Only three of 21 included studies had high quality, whereas 93% of substudies reported lung function improvement with an overall pooled standardised mean difference (SMD) of 0.53 (95% CI 0.43–0.62). The measured effect of HACT was greater in adults (SMD 0.75, 95% CI 0.63–0.88, n=14) than in children (SMD 0.24, 95% CI 0.09–0.38, n=14). Studies at altitude >2000 m above sea level yielded the same effect as those at lower altitude. Based on a cut-point of a 0.50 change in SMD to define a meaningful clinical difference, HACT appears to have efficacy as an intervention. This extent of benefit appears to be limited to adults with asthma.

31 March 2011 in High Altitude Medicine & Biology
Verified
Journal Article
Closed access
DVDenis Vinnikov
Denis Vinnikov
NBNurlan Brimkulov
Nurlan Brimkulov
RRRupert Redding-Jones
Rupert Redding-Jones
Vinnikov, Denis, Nurlan Brimkulov, and Rupert Redding-Jones. Four-year prospective study of lung function in workers in a high altitude (4000 m) mine. High Alt. Med. Biol. 12:65–69, 2011.—The aim of this study was to determine if work at high altitude is associated with accelerated lung function decline and if smoking could further accelerate this decline. Subjects working at high altitude (3800 to 4500 m) in a gold mine on shift-rotation basis were included, and 7320 spirometry reports were obtained throughout a 4-yr observation period (2005–2009). Out of 3368 selected reports with acceptable quality, for 842 patients aged 38.9 ± 8.6 yr we analyzed annual decline in vital capacity (VC), forced vital capacity (FVC), and forced expiratory volume during the first second (FEV 1 ). VC was reduced by 46.5 mL, FVC by 67.8 mL, and FEV 1 by 74.5 mL a year, greater than in historical controls. In those having initial FEV 1 /FVC below 70%, yearly VC decline was 59.4 mL, FEV 1 −58.6 mL. In long-term workers with no initial obstruction, FEV 1 declined slower (67.2 vs. 101.3 mL/yr ( p < 0.001); but VC and FVC decline did not differ. Work at high altitude for years may be a factor that accelerates lung function decline, and the rate of decline along with confounding factors should be the subject of future studies.

1 March 2016 in High Altitude Medicine & Biology
Verified
Journal Article
Closed access
DVDenis Vinnikov
Denis Vinnikov
NBNurlan Brimkulov
Nurlan Brimkulov
VKViktor Krasotski
Viktor Krasotski
Vinnikov, Denis, Nurlan Brimkulov, and Viktor Krasotski. Chronic intermittent hypoxia and blood pressure: Is there risk for hypertension in healthy individuals? High Alt Med Biol. 00:000–000, 2015.—Aim: The aim of the current study was to assess a year-long impact of chronic intermittent exposure to hypoxia on blood pressure (BP) in healthy working middle-aged adults. Materials and Methods: Data from pre-employment and annual screening of high-altitude mining company (elevation 4000 meters above sea level) were obtained for 472 workers aged 34.1 ± 7.8 years, working 2-week shifts, followed by 2 weeks of rest at low altitude (cumulative exposure 6 months). Overall systolic, diastolic BP change (ΔBP) were calculated, and tested in multivariate regression models in the entire group, as well as in different strata of BP. Results: Baseline systolic BP reduced from 123.2 ± 11.3 to 116.3 ± 13.1 mmHg (ΔBP 6.8 mmHg), diastolic BP from 76.7 ± 8.4 to 74.9 ± 8.4 mmHg (ΔBP −1.7 mmHg) (p < 0.001), both measured at low altitude before and after one year of exposure to chronic intermittent hypoxia. The greater the baseline BP, the more pronounced was BP decrease. In the most prevalent combined group of normal and high normal BP, both systolic and diastolic BP reduced after one year of high altitude exposure (p < 0.01). In multivariate adjusted models, none of exposures of interest were associated with ΔBP. Conclusions: One-year intermittent exposure to hypobaric hypoxia in new hires for high-altitude mining company was not associated with BP increase.

7 July 2014 in Occupational Medicine
Verified
Journal Article
Closed access
DVDenis Vinnikov
Denis Vinnikov
NBN. Brimkulov
N. Brimkulov
VKV. Krasotski
V. Krasotski
RRR. Redding-Jones
R. Redding-Jones
PBP. D. Blanc
P. D. Blanc
Studies of occupational acute mountain sickness (AMS) have not focused on the more severe end of the spectrum to date. To examine risk factors associated with the development of occupational AMS severe enough to receive treatment in a compression chamber. A nested case referent study in a cohort of high-altitude (4000 m) mine workers, comparing cases of severe, chamber-treated AMS to matched referents. Using logistic regression, we tested potential risk factors based on premorbid surveillance examinations, including cigarette smoking (current smoking, smoking intensity and exhaled carbon monoxide [CO]). There were 15 cases and 30 controls. In multivariate analysis including age, sex and place of residence, current smoking was associated with increased risk of severe AMS (odds ratio [OR] 10.0; 95% confidence interval [CI] 1.5-67.4), taking into account any prior, less severe AMS event, which was also a potent risk factor (OR 33.3; 95% CI 2.8-390). Smoking intensity (cigarettes per day) and exhaled CO were also statistically significantly associated with severe AMS. Cigarette smoking is a strong, previously under-appreciated risk factor for severe AMS. Because this is a modifiable factor, these findings suggest that workplace-based smoking cessation should be tested as an intervention to prevent such morbidity.

1 December 2013 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
DVDenis Vinnikov
Denis Vinnikov
PBPaul D. Md Blanc
Paul D. Md Blanc
NBNurlan Brimkulov
Nurlan Brimkulov
RRRupert Redding-Jones
Rupert Redding-Jones
Objective: To assess the annual lung function decline associated with the reduction of secondhand smoke exposure in a high-altitude industrial workforce. Methods: We performed pulmonary function tests annually among 109 high-altitude gold-mine workers over 5 years of follow-up. The first 3 years included greater likelihood of exposure to secondhand smoke exposure before the initiation of extensive smoking restrictions that came into force in the last 2 years of observation. Results: In repeated measures modeling, taking into account the time elapsed in relation to the smoking ban, there was a 115 ± 9 (standard error) mL per annum decline in lung function before the ban, but a 178 ± 20 (standard error) mL per annum increase afterward (P < 0.001, both slopes). Conclusion: Institution of a workplace smoking ban at high altitude may be beneficial in terms of lung function decline.